Adjuvanted Vaccines Associated with Lower Dementia Risk
July 8, 2025
More evidence is emerging that vaccines may contribute to a lower risk of dementia.
3 min read

False
The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.
After his postdoc, Simon Tasker joined Colorcon as a bench chemist – and never left. Today, he’s the company’s CEO. Here’s how his career unfolded as he grew within the company he now leads.
All the latest Medicine Maker articles.
July 3, 2025
Find out more about the new Sartorius campus in southern France built for automation, smart manufacturing, and sustainability.
2 min read
July 3, 2025
With biologics workflows growing increasingly complex, laboratories are embracing smarter, scalable automation to overcome persistent bottlenecks and drive innovation. Dieter Wagner, Product Manager at Thermo Fisher Scientific, shares insights on the evolving demands of cell culture – and the technologies helping to meet them.
7 min read
July 2, 2025
Our latest news roundup reports on how CRISPR/Cas9 improves ASOs efficacy, Abbvie’s latest acquisition, further sickle cell disease research, and more
3 min read
July 2, 2025
A new dual agonist GLP-1 is showing weight loss without gastrointestinal side effects and appetite suppression. We speak with the company to learn more.
3 min read
July 1, 2025
Since the FDA announced plans to phase out mandatory animal testing, in silico drug discovery and development platforms are emerging. Welcome to the age of biosimulation.
6 min read
July 1, 2025
Our latest news roundup reports on thimerosal elimination, subscription termination, depression alleviation, and more
4 min read
June 30, 2025
We ask experts for their views on the GLP-1 market in this exclusive eBook.
1 min read
June 30, 2025
We sit down with Audrey Greenberg to discuss investment, cell therapy, and what to look for when hiring talent.
6 min read
June 27, 2025
Researchers have developed a new way to create covalent peptide inhibitors of transcription factors – proteins once considered “undruggable.”
8 min read
False